Target intelligence / Profile preview

Leucine-rich repeat-containing protein 37A3 (LRRC37A3)

Target: LRRC37A3
Molecular classification: Single-span transmembrane protein, Leucine-rich repeat (LRR) family protein, Other: not a G protein-coupled receptor, ion channel, enzyme, transporter, or transcription factor

Overview

Leucine-rich repeat-containing protein 37A3 (LRRC37A3) is a member of the LRR family located on human chromosome 17q21.31 in a region subject to extensive segmental duplications and genomic rearrangements. The protein is predicted to be a single-pass transmembrane protein with extracellular leucine-rich repeat motifs, localizing primarily to the Golgi apparatus and plasma membrane—where it may be cleaved and secreted—suggesting roles in vesicular transport or cell surface dynamics. LRRC37A3 is expressed in specific cell types such as retinal rod cells and has been implicated—through genetic studies—in congenital syndromes with neurological and systemic features. Dysregulation in this locus may be linked to neurodevelopmental and neurodegenerative disorders via indirect mechanisms, though its precise biological function is poorly understood and not connected to any known pharmacological interventions.

Other names: LRRC37A3KIAA0563FLJ34306LRRC37LRRC37Aleucine rich repeat containing 37 member A3Leucine-rich repeat-containing protein 37A3

Mechanism of action

None established; not a known drug target or mechanistic node in pharmacology

Biological functions

Putative involvement in membrane biology and vesicle trafficking (based on subcellular localization)Potential role in dendritic growth and branching in cortical neurons (fusion studies with KANSL1 suggest transcriptional activator activity in neuronal growth)Marker for retinal rod cells; may relate to photoreceptor identity or functionMay influence cell shape and membrane dynamics (overexpression studies cause filopodia-like protrusions)Possibly modulates neurodevelopmental pathways

Disease associations

Variant in LRRC37A3 is associated with clinical syndromes: growth retardation, intellectual disability, joint contracture, and hepatopathyLocated in chromosome region linked to neurodevelopmental and neurodegenerative conditions (region implicated in Parkinson’s disease and dementia but not directly attributed to LRRC37A3)Detected in fusion events in cancer genomic studies, but no definitive disease mechanism as a direct targetOther: possible indirect roles in neurological and developmental disorders

Safety considerations

None documented; therapeutic challenges not addressed since it is not a known drug target

Biomarkers

Distinctive marker for retinal rod cells (could have potential as a tissue or cell-type marker, but no published clinical biomarker status)No clinical biomarkers established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Leucine-rich repeat-containing protein 37A3 (LRRC37A3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat-containing protein 37A3 (LRRC37A3).

Explore the full profile